SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 30, 16:00
388.55
2.95 (0.77%)
VOLUME 34,186
LIVE
NSE
Sep 30, 15:56
387.80
1.1 (0.28%)
VOLUME 348,271
News on Cadila Healthcare
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Stocks in news: M&M, Aurobindo, Jindal Stainless, Balaji Tele

8.01 am | 28 Sep 2016 |  Source: CNBC-TV18

M&M | Lupin | Torrent Pharma | Cadila | Ahluwalia Contracts | RBL Bank | Jindal Stainless | Dalmia Bharat | Cenlub Industries | ARSS Infra | Maithan A...

Aurobindo Pharma, Cadila recall drugs from US market

5.38 pm | 21 Sep 2016 |  Source: PTI

Amerisource Health Services is recalling 2,626 bottles of Bupropion Hydrochloride extended-release tablets USP (XL), 300 mg manufactured by Ahemdabad ...

Top buzzing midcap stocks to trade on September 20 

12.31 pm | 20 Sep 2016 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Jubilant Foodworks, Castrol, Dr Reddys, Mangalam Cemen...

Cadila Healthcare rises 6%, to develop chikungunya vaccine

11.56 am | 20 Sep 2016 |  Source: Moneycontrol.com

The agreement includes early stage development to the final commercialisation of the vaccine....

Cadila to complete remediation for Moraiya unit by Sep: Sources 

11.09 am | 20 Sep 2016 |  Source: CNBC-TV18

The company had received warning letters for Moraiya and Zyfine plants in December last year. Zyfine facility, however, will take another 3-4 moths fo...

Zydus and Takeda enter into partnership to address emerging infectious diseases

10.37 am | 20 Sep 2016 |  Source: Moneycontrol.com

Zydus Cadila and Takeda Pharmaceutical Company announced a partnership to tackle Chikungunya, an emerging infectious disease....

Credit Suisse downgrades Cadila; Moraiya clearance key to growth

12.48 pm | 19 Sep 2016 |  Source: Moneycontrol.com

Credit Suisse has downgraded Cadila Healthcare to neutral as the stock is already factoring in clearance of the Moraiya facility and any delay could i...

Zydus recalls 14,800 bottles of Bromocriptine Mesylate capsule

9.00 am | 15 Sep 2016 |  Source: PTI

According to information available on the United States Food and Drug Administration (USFDA) site, Zydus Pharmaceuticals USA Inc is recalling drugs ma...

Buy Cipla 600 Call, Cadila Healthcare 300 Call: VK Sharma 

11.23 am | 09 Sep 2016 |  Source: CNBC-TV18

According to VK Sharma, Head Private Broking & Wealth Management at HDFC Securities, one can buy Cipla 600 Call and Cadila Healthcare 300 Call....

Buy Lupin, Cadila Healthcare: Mitesh Thacker 

3.20 pm | 08 Sep 2016 |  Source: CNBC-TV18

Mitesh Thacker of miteshthacker.com recommends buying Lupin and Cadila Healthcare. ...

Cadila up 4% on EIR report from USFDA for Ahmedabad SEZ unit

11.50 am | 02 Sep 2016 |  Source: Moneycontrol.com

"Oral solid dosage drug manufacturing plant located at SEZ, Ahmedabad has received an establishment inspection report (EIR) from the USFDA," the pharm...

Cadila Healthcare gets EIR for Ahmedabad plant from USFDA

11.20 am | 02 Sep 2016 |  Source: PTI

"The company's Oral Solid Dosage drug manufacturing plant located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) from the USF...

Bull's Eye: Buy Ipca Lab, Cadila Health, Just Dial; sell HDIL 

7.54 am | 26 Aug 2016 |  Source: CNBC-TV18

Sameet Chavan of Angel Broking is of the view that one may buy TVS Motor with a target of Rs 322....

Buy Sanghi Industries, Axis Bank, Natco Pharma: Mitesh Thacker 

11.48 am | 25 Aug 2016 |  Source: CNBC-TV18

According to Mitesh Thacker of miteshthacker.com, one can buy Sanghi Industries, Axis Bank and Natco Pharma....

Hold Cadila Healthcare; target of Rs 350: Axis Direct

6.34 pm | 05 Aug 2016 |  Source: Moneycontrol.com

Axis Direct has recommended hold rating on Cadila Healthcare with a target price of Rs 350 in its research report dated August 05, 2016....

Buy Cadila Healthcare; target of Rs 370: Religare

6.26 pm | 05 Aug 2016 |  Source: Moneycontrol.com

Religare is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 370 in its research report dated August 03,...

Hold Cadila Healthcare; target of Rs 315: Edelweiss

6.06 pm | 04 Aug 2016 |  Source: Moneycontrol.com

Edelweiss has recommended hold rating on Cadila Healthcare with a target price of Rs 315 in its research report dated August 04, 2016....

Buy Cadila Health; target of Rs 400: Motilal Oswal

1.19 pm | 04 Aug 2016 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 400 in its research report dated August 03...

Cadila Healthcare Q1 net dips 23% to Rs 356 cr 

9.58 pm | 03 Aug 2016 |  Source: PTI

Drug firm Cadila Healthcare today reported a 22.59 per cent dip in consolidated net profit to Rs 356.2 crore for the quarter ended June 30....

Cadila HC Q1 PAT seen down by 8.8% at Rs 354.6 cr: Religare

1.15 pm | 16 Jul 2016 |  Source: Moneycontrol.com

Sales are expected to increase by 0.2 percent Q-o-Q (down 1.9 percent Y-o-Y) to Rs 2453.8 crore, according to Religare Research. ...

1 2 3 4 5
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.